Molecular typing is based on molecular genetic testing and is not but routinely offered. Molecular subtypes and immunohistochemical surrogate markers of your tumors (HR, HER2, triple destructive) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-sixty seven could https://nielsonc197frb9.bloggerswise.com/profile